Stéphane Bancel is a French business leader and engineer who has served as the Chief Executive Officer of Moderna since 2011. He has helped transform Moderna from a young biotechnology startup into one of the world's most recognized biotechnology companies, focused on using messenger RNA (mRNA) technology to develop new medicines.
Born and raised in Marseille, France, Stéphane developed an interest in math, science, and computers at a young age. He studied engineering in France before coming to the United States, where he earned a master's degree in chemical engineering from the University of Minnesota. He later earned an MBA from Harvard Business School.
Before joining Moderna, Stéphane built his career in the healthcare and biotechnology industries. He held several leadership positions at Eli Lilly and later became CEO of the French diagnostics company bioMérieux. In 2011, he took on the challenge of leading Moderna when the company was still in its very early stages.
Under Stéphane's leadership, Moderna has grown into a global biotechnology company exploring how mRNA technology can be used to create new medicines and address challenging health problems. His work requires bringing together scientists, engineers, physicians, technology experts, and business leaders to turn ambitious scientific ideas into real-world innovations.
Stéphane's journey is an excellent example for students of how science, engineering, technology, entrepreneurship, and leadership can come together in one career. His story also demonstrates the importance of education, curiosity, taking calculated risks, learning from challenges, and being willing to pursue ideas that could change the future.
For students interested in STEM, biotechnology, engineering, medicine, entrepreneurship, technology, or business leadership, Stéphane's career provides a fascinating look at how scientific innovation can move from an idea in a laboratory to something capable of making an impact around the world.
